CEL-SCI Corporation news

   Watch this stock
Showing stories 51 - 60 of about 88   

Articles published

CVM 1.96 +0.06 (3.16%)
price chart
Hot Stocks News Headlines for Today: World Acceptance Corporation (WRLD), CEL ...
World Acceptance Corporation (NASDAQ:WRLD) shares ended at $82.11 with 0.06 mln shares exchanging hands. That puts the market capitalization at $746.38 mln.
Tracking the one year Price Target on CEL-SCI Corporation (CVM)
Cel-Sci Corporation (NYSEMKT:CVM) stock ended the last trade transaction at $1.71. The 50-Day Moving Average price noticed at $1.79 and the 200 Day Moving Average price is at $1.21.
5 Stocks To Watch For January 2, 2018
Ocean Rig UDW Inc. (NASDAQ: ORIG) named Pankaj Khanna as CEO effective January 1st, 2018. Ocean Rig shares rose 2.68 percent to close at $26.80 on Friday.
Short Interest in CEL-SCI Co. (CVM) Rises By 14.0%
CEL-SCI Co. (NYSEAMERICAN:CVM) was the recipient of a significant growth in short interest during the month of December. As of December 15th, there was short interest totalling 526,760 shares, a growth of 14.0% from the November 30th total of 462,000 ...
Short Interest in CEL-SCI Co. (NYSEAMERICAN:CVM) Expands By 14.0%
CEL-SCI Co. (NYSEAMERICAN:CVM) was the target of a large increase in short interest in the month of December. As of December 15th, there was short interest totalling 526,760 shares, an increase of 14.0% from the November 30th total of 462,000 shares ...
CEL-SCI Co. (CVM) Short Interest Up 14.0% in December  StockNewsTimes
CEL-SCI Corporation (CVM) Revealing Matters Taking Place In Stock Swing
CEL-SCI Corporation (CVM) delivered a increase of 4.30% return at the end of Wednesday trading. CVM stock closed at $1.94 after trading 1.13 million shares at hands unusually.
Market Check: These Shares Up 14.74% Over the Last Month: Cel-Sci Corp (CVM)
Taking a closer look at shares of Cel-Sci Corp (CVM), we have noted that the stock price has risen 14.74% over the last 4-weeks.
Cervical Intraepithelial Neoplasia – Companies Involved in Therapeutics ...
A new independent 90 page research with title 'Cervical Intraepithelial Neoplasia {CIN} - Pipeline Review, H2 2017' guarantees you will remain better informed than your competition.
CEL-SCI Co. (CVM) Short Interest Update
CEL-SCI logo CEL-SCI Co. (NYSEAMERICAN:CVM) was the target of a large increase in short interest in December. As of December 15th, there was short interest totalling 526,760 shares, an increase of 14.0% from the November 30th total of 462,000 shares ...
CEL-SCI's LEAPS platform technology to treat rheumatoid arthritis receives ...
CEL-SCI Corporation, a phase 3 cancer immunotherapy company, announced that the European Patent Office has issued CEL-SCI patent EP 2254588B1 titled, "Method of Preparation and Composition of Peptide Constructs for Treatment of Rheumatoid Arthritis ...